Header Logo

Connection

Fawzia Bardag to Mice

This is a "connection" page, showing publications Fawzia Bardag has written about Mice.
Connection Strength

1.037
  1. Delta-aminolevulinic dehydratase is a proteasome interacting protein. Exp Mol Pathol. 2011 Oct; 91(2):485-9.
    View in: PubMed
    Score: 0.079
  2. SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model. Exp Mol Pathol. 2010 Jun; 88(3):353-62.
    View in: PubMed
    Score: 0.073
  3. SAMe prevents the up regulation of toll-like receptor signaling in Mallory-Denk body forming hepatocytes. Exp Mol Pathol. 2010 Jun; 88(3):376-9.
    View in: PubMed
    Score: 0.072
  4. Epigenetic mechanisms regulate Mallory Denk body formation in the livers of drug-primed mice. Exp Mol Pathol. 2008 Apr; 84(2):113-21.
    View in: PubMed
    Score: 0.062
  5. Mallory body formation is associated with epigenetic phenotypic change in hepatocytes in vivo. Exp Mol Pathol. 2007 Oct; 83(2):160-8.
    View in: PubMed
    Score: 0.059
  6. CYP2E1 inhibition enhances mallory body formation. Exp Mol Pathol. 2005 Jun; 78(3):207-11.
    View in: PubMed
    Score: 0.051
  7. Proteasome inhibition induces cytokeratin accumulation in vivo. Exp Mol Pathol. 2004 Apr; 76(2):83-9.
    View in: PubMed
    Score: 0.048
  8. The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation. Exp Mol Pathol. 2004 Feb; 76(1):9-16.
    View in: PubMed
    Score: 0.048
  9. The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1). Exp Mol Pathol. 2003 Apr; 74(2):160-7.
    View in: PubMed
    Score: 0.045
  10. The role of the ubiquitin-proteasome pathway in the formation of mallory bodies. Exp Mol Pathol. 2002 Oct; 73(2):75-83.
    View in: PubMed
    Score: 0.043
  11. Mallory bodies formed in proteasome-depleted hepatocytes: an immunohistochemical study. Exp Mol Pathol. 2001 Feb; 70(1):7-18.
    View in: PubMed
    Score: 0.039
  12. The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol. Biochem Biophys Res Commun. 2000 Dec 09; 279(1):23-9.
    View in: PubMed
    Score: 0.038
  13. FAT10 knock out mice livers fail to develop Mallory-Denk bodies in the DDC mouse model. Exp Mol Pathol. 2012 Dec; 93(3):309-14.
    View in: PubMed
    Score: 0.022
  14. Ethanol and hepatitis C virus suppress peptide-MHC class I presentation in hepatocytes by altering proteasome function. Alcohol Clin Exp Res. 2012 Dec; 36(12):2028-35.
    View in: PubMed
    Score: 0.021
  15. Mallory-Denk bodies form when EZH2/H3K27me3 fails to methylate DNA in the nuclei of human and mice liver cells. Exp Mol Pathol. 2012 Jun; 92(3):318-26.
    View in: PubMed
    Score: 0.021
  16. The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model. Exp Mol Pathol. 2011 Dec; 91(3):653-9.
    View in: PubMed
    Score: 0.020
  17. Puromycin-sensitive aminopeptidase (PSA/NPEPPS) impedes development of neuropathology in hPSA/TAU(P301L) double-transgenic mice. Hum Mol Genet. 2011 May 01; 20(9):1820-33.
    View in: PubMed
    Score: 0.019
  18. Independent phenotype of binuclear hepatocytes and cellular localization of UbD. Exp Mol Pathol. 2010 Oct; 89(2):103-8.
    View in: PubMed
    Score: 0.019
  19. S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes. Hepatology. 2010 Jun; 51(6):2152-61.
    View in: PubMed
    Score: 0.018
  20. The regulation of non-coding RNA expression in the liver of mice fed DDC. Exp Mol Pathol. 2009 Aug; 87(1):12-9.
    View in: PubMed
    Score: 0.017
  21. Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms. Exp Mol Pathol. 2009 Apr; 86(2):77-86.
    View in: PubMed
    Score: 0.017
  22. S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory. Hepatology. 2008 Feb; 47(2):613-24.
    View in: PubMed
    Score: 0.016
  23. Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis. Exp Mol Pathol. 2008 Apr; 84(2):102-12.
    View in: PubMed
    Score: 0.016
  24. Regulation of murine cardiac 20S proteasomes: role of associating partners. Circ Res. 2006 Aug 18; 99(4):372-80.
    View in: PubMed
    Score: 0.014
  25. Mapping the murine cardiac 26S proteasome complexes. Circ Res. 2006 Aug 18; 99(4):362-71.
    View in: PubMed
    Score: 0.014
  26. Preneoplastic liver cell foci expansion induced by thioacetamide toxicity in drug-primed mice. Exp Mol Pathol. 2006 Aug; 81(1):8-14.
    View in: PubMed
    Score: 0.014
  27. Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor. Exp Mol Pathol. 2006 Jun; 80(3):228-40.
    View in: PubMed
    Score: 0.014
  28. Mallory body forming cells express the preneoplastic hepatocyte phenotype. Exp Mol Pathol. 2006 Apr; 80(2):109-18.
    View in: PubMed
    Score: 0.014
  29. The role of laminin-integrin signaling in triggering MB formation. An in vivo and in vitro study. Exp Mol Pathol. 2005 Aug; 79(1):1-8.
    View in: PubMed
    Score: 0.013
  30. The p105/50 NF-kappaB pathway is essential for Mallory body formation. Exp Mol Pathol. 2005 Jun; 78(3):198-206.
    View in: PubMed
    Score: 0.013
  31. RNA interference of VCP/p97 increases Mallory body formation. Exp Mol Pathol. 2005 Feb; 78(1):1-9.
    View in: PubMed
    Score: 0.013
  32. p62 is involved in the mechanism of Mallory body formation. Exp Mol Pathol. 2004 Dec; 77(3):168-75.
    View in: PubMed
    Score: 0.013
  33. Retinoid X receptor alpha regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver. Mol Pharmacol. 2004 Mar; 65(3):550-7.
    View in: PubMed
    Score: 0.012
  34. Heat shock proteins are present in mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens. Exp Mol Pathol. 2003 Apr; 74(2):168-72.
    View in: PubMed
    Score: 0.011
  35. Microtubules are required for cytokeratin aggresome (Mallory body) formation in hepatocytes: an in vitro study. Exp Mol Pathol. 2003 Apr; 74(2):173-9.
    View in: PubMed
    Score: 0.011
  36. Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin. Exp Mol Pathol. 2001 Dec; 71(3):241-6.
    View in: PubMed
    Score: 0.010
  37. The ubiquitin-proteasome 26s pathway in liver cell protein turnover: effect of ethanol and drugs. Alcohol Clin Exp Res. 2001 May; 25(5 Suppl ISBRA):225S-229S.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.